82 related articles for article (PubMed ID: 36200940)
1. The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.
Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; Deprez J; Van den Bosch F; Elewaut D; Peene I
Clin Exp Rheumatol; 2022 Dec; 40(12):2310-1317. PubMed ID: 36200940
[TBL] [Abstract][Full Text] [Related]
2. Seronegative patients with primary Sjögren's syndrome and non-pSS sicca test positive for anti-SSA/Ro52 and -Ro60 in saliva.
Kamounah S; Wei F; Park JK; Song YW; Chia D; Wong DTW; Pedersen AML
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167168. PubMed ID: 38641012
[TBL] [Abstract][Full Text] [Related]
3. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
[TBL] [Abstract][Full Text] [Related]
4. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V;
Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
Bodakçi E
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and immunological features of primary Sjögren's syndrome patients with positive anti-centromere protein B antibody].
Meng YH; Chen YF; Zhou PR
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1088-1096. PubMed ID: 38101794
[TBL] [Abstract][Full Text] [Related]
8. Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren's syndrome and Sicca.
Chiang S; Grogan T; Kamounah S; Wei F; Tayob N; Kim JY; Kyun Park J; Akin D; Elashoff DA; Pedersen AML; Song YW; Wong DTW; Chia D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599651
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and biopsy accuracy in suspected cases of Sjögren's syndrome referred to labial salivary gland biopsy.
Giovelli RA; Santos MC; Serrano ÉV; Valim V
BMC Musculoskelet Disord; 2015 Feb; 16():30. PubMed ID: 25887888
[TBL] [Abstract][Full Text] [Related]
10. Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren's Syndrome.
Kamounah S; Tayob N; Chiang S; Wei F; Park JK; Kwon HM; Feng Z; Chia D; Pedersen AML; Song YW; Wong DTW
Immunohorizons; 2023 Jul; 7(7):554-561. PubMed ID: 37466644
[TBL] [Abstract][Full Text] [Related]
11. Impression Cytology and
Hao R; Liu Z; Chou Y; Wang Y; Ren X; Jiang X; Li X
Front Immunol; 2022; 13():829320. PubMed ID: 35585979
[TBL] [Abstract][Full Text] [Related]
12. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody].
Han YJ; Li CH; Chen XY; Zhao JX
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1000-1006. PubMed ID: 38101780
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Single-Cell Sequencing of B Cells in Primary Sjögren's Syndrome.
Arvidsson G; Czarnewski P; Johansson A; Raine A; Imgenberg-Kreuz J; Nordlund J; Nordmark G; Syvänen AC
Arthritis Rheumatol; 2024 Feb; 76(2):255-267. PubMed ID: 37610265
[TBL] [Abstract][Full Text] [Related]
15. Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.
Mazeda C; Oliveira N; Abreu C; Fraga V; Maduro I; Saraiva A; Inês L; Ferreira C; Correia AM; Nicolau R; Farinha F; Villanueva I; Jesus D; Abreu P; Neto A; Silva Dinis J; Barcelos A
Clin Exp Rheumatol; 2024 Mar; ():. PubMed ID: 38530658
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.
Luo J; Xu S; Lv Y; Huang X; Zhang H; Zhu X; Wang X
Int J Rheum Dis; 2019 Feb; 22(2):182-190. PubMed ID: 30411528
[TBL] [Abstract][Full Text] [Related]
17. The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies.
Valle A; Narain S; Barilla-Labarca ML; Marder G
Semin Arthritis Rheum; 2024 Apr; 65():152407. PubMed ID: 38377624
[TBL] [Abstract][Full Text] [Related]
18. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
[TBL] [Abstract][Full Text] [Related]
19. The proportion of CD161 on CD56
Zhao P; Yang Y; Song S; Cheng W; Peng C; Chang X; Wu J; Liu C
Immun Inflamm Dis; 2024 Apr; 12(4):e1244. PubMed ID: 38577997
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a Sjögren's disease-like phenotype following COVID-19.
Shen Y; Voigt A; Goranova L; Abed M; Kleiner DE; Maldonado JO; Beach M; Pelayo E; Chiorini JA; Craft WF; Ostrov DA; Ramiya V; Sukumaran S; Tuanyok A; Warner BM; Nguyen CQ
medRxiv; 2022 Oct; ():. PubMed ID: 36324812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
